Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Related Articles by Review for PubMed (Select 15276392)

1.

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators.

Lancet. 2004 Jul 24-30;364(9431):331-7.

PMID:
15276392
2.
3.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

4.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

5.

[Adding aspirin to clopidogrel in secondary prevention of ischemic stroke: no significant benefits. Results of the Match study].

Calvet D, Touzé E, Mas JL.

Presse Med. 2006 Apr;35(4 Pt 2):679-82. Review. French.

PMID:
16614614
6.

MATCH results: implications for the internist.

Lutsep HL.

Am J Med. 2006 Jun;119(6):526.e1-7. Review.

PMID:
16750967
7.

Clopidogrel: a review of its use in the prevention of atherothrombosis.

Jarvis B, Simpson K.

Drugs. 2000 Aug;60(2):347-77. Review. Erratum in: Drugs 2001;61(1):52.

PMID:
10983738
8.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
9.

Evidence with antiplatelet therapy and ADP-receptor antagonists.

Easton JD.

Cerebrovasc Dis. 2003;16 Suppl 1:20-6. Review.

PMID:
12698015
12.
13.

Role of antiplatelet drugs in the prevention of cardiovascular events.

Tendera M, Wojakowski W.

Thromb Res. 2003 Jun 15;110(5-6):355-9. Review.

PMID:
14592562
14.

Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.

Geeganage CM, Diener HC, Algra A, Chen C, Topol EJ, Dengler R, Markus HS, Bath MW, Bath PM; Acute Antiplatelet Stroke Trialists Collaboration.

Stroke. 2012 Apr;43(4):1058-66. doi: 10.1161/STROKEAHA.111.637686. Epub 2012 Jan 26. Review.

15.

Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

Kirshner HS.

Int J Clin Pract. 2007 Oct;61(10):1739-48. Review. Erratum in: Int J Clin Pract. 2007 Nov;61(11):1957.

16.
17.
18.
19.
20.

Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.

Hankey GJ, Eikelboom JW.

Neurology. 2005 Apr 12;64(7):1117-21. Review.

PMID:
15824331
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk